Article
An AML1-ETO/miR-29b-1 regulatory circuit modulates phenotypic properties of acute myeloid leukemia cells.
Oncotarget - 20 Jun 2017
Zaidi Sayyed K, Perez Andrew W, White Elizabeth S, Lian Jane B, Stein Janet L, Stein Gary S
Abstract excerpt
Acute myeloid leukemia (AML) is characterized by an aggressive clinical course and frequent cytogenetic abnormalities that include specific chromosomal translocations. The 8;21 chromosomal rearrangement disrupts the key hematopoietic RUNX1 transcription factor, and contributes to leukemia through recruitment of co-repressor complexes to RUNX1 target genes, altered subnuclear localization, and deregulation of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
